Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Adams

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Pediatrics|March 8, 2021
Case Report: Neonatal Unexplained HUS Treated With Complement Inhibitor EculizumabDorottya Kelen, Benedetta Chiodini, Valérie Godart, et al.
Frontiers in Pediatrics|January 24, 2022
Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1Benedetta Chiodini, Nathalie Tram, Brigitte Adams, et al.
Frontiers in Pediatrics|May 7, 2021
The Struggling Odyssey of Infantile Primary HyperoxaluriaAdrien Guillaume, Benedetta Chiodini, Brigitte Adams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
CD8+ T lymphocytes regulating Th2 pathology escape neonatal tolerizationBrigitte Adams, Nathalie Nagy, Frédéric Paulart, et al.
BMC Medical Genetics|March 17, 2017
Early-onset of ADCK4 glomerulopathy with renal failure: a case reportKsenija Lolin, Benedetta D Chiodini, Elise Hennaut, et al.
Biomedicines|February 27, 2026
The Burden of BK Polyomavirus in Pediatric Renal Transplantation: A Belgian ExperiencePauline Guillaume-Gentil, Benedetta Chiodini, Brigitte Adams, et al.
Pediatrics|May 21, 2014
Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndromeBenedetta Diamante Chiodini, Jean-Claude Davin, Francis Corazza, et al.
Pediatric Nephrology (Berlin, Germany)|October 13, 2020
The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumabKazuki Tanaka, Brigitte Adams, Alvaro Madrid Aris, et al.
Frontiers in Pediatrics|September 21, 2018
Prospective Cohort Study Investigating the Safety and Efficacy of Ambulatory Treatment With Oral Cefuroxime-Axetil in Febrile Children With Urinary Tract InfectionElise Hennaut, Hong P Duong, Benedetta Chiodini, et al.
Journal of Translational Internal Medicine|February 9, 2022
Hyperoxaluria: An early diagnosis will allow a timely combined renal and liver transplantations to avoid irreversible damages to all other organsElisa Kottos, Brigitte Adams, Dominique Biarent, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Pediatrics|March 8, 2021
Case Report: Neonatal Unexplained HUS Treated With Complement Inhibitor EculizumabDorottya Kelen, Benedetta Chiodini, Valérie Godart, et al.
Frontiers in Pediatrics|January 24, 2022
Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1Benedetta Chiodini, Nathalie Tram, Brigitte Adams, et al.
Frontiers in Pediatrics|May 7, 2021
The Struggling Odyssey of Infantile Primary HyperoxaluriaAdrien Guillaume, Benedetta Chiodini, Brigitte Adams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
CD8+ T lymphocytes regulating Th2 pathology escape neonatal tolerizationBrigitte Adams, Nathalie Nagy, Frédéric Paulart, et al.
BMC Medical Genetics|March 17, 2017
Early-onset of ADCK4 glomerulopathy with renal failure: a case reportKsenija Lolin, Benedetta D Chiodini, Elise Hennaut, et al.
Biomedicines|February 27, 2026
The Burden of BK Polyomavirus in Pediatric Renal Transplantation: A Belgian ExperiencePauline Guillaume-Gentil, Benedetta Chiodini, Brigitte Adams, et al.
Pediatrics|May 21, 2014
Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndromeBenedetta Diamante Chiodini, Jean-Claude Davin, Francis Corazza, et al.
Pediatric Nephrology (Berlin, Germany)|October 13, 2020
The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumabKazuki Tanaka, Brigitte Adams, Alvaro Madrid Aris, et al.
Frontiers in Pediatrics|September 21, 2018
Prospective Cohort Study Investigating the Safety and Efficacy of Ambulatory Treatment With Oral Cefuroxime-Axetil in Febrile Children With Urinary Tract InfectionElise Hennaut, Hong P Duong, Benedetta Chiodini, et al.
Journal of Translational Internal Medicine|February 9, 2022
Hyperoxaluria: An early diagnosis will allow a timely combined renal and liver transplantations to avoid irreversible damages to all other organsElisa Kottos, Brigitte Adams, Dominique Biarent, et al.
Pageof 3